20251301_ITM and Ariceum Therapeutics Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 ...

EQS-News: Eckert & Ziegler SE / Key word (s): Alliance/Incoming Orders Eckert & Ziegler and GlyTherix Extend Collaboration With Actinium-225 Supply Agreement 13.01.2025 / 10:00 CET/CEST The issuer ...

Korea is set to begin domestic production of actinium-225 (Ac-225), a key raw material for next-generation cancer treatments, ...

Actinium Pharmaceuticals ( (ATNM)) has released its Q3 earnings. Here is a breakdown of the information Actinium Pharmaceuticals presented to its investors. Actinium Pharmaceuticals, Inc. is a ...

Bill Gates' nuclear power venture, TerraPower Isotopes, has become the first to boost production of a radioactive substance that has shown new promise in the fight against cancer, called actinium ...

NEW YORK (AP) — NEW YORK (AP) — Actinium Pharmaceuticals Inc. (ATNM) on Thursday reported a loss of $11.6 million in its third quarter. On a per-share basis, the New York-based company said it ...

(RTTNews) - Actinium Pharmaceuticals Inc. (ATNM) Monday announced a narrower loss for the third quarter. The September quarter loss was $11.6 million, compared to $13.3 million a year ago.

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, and ITM Isotope Technologies Munich ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Garching / Munich / Berlin, Germany, January 13, 2025 - ITM Isotope Technologies Munich SE(Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment o ...